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Abstract Collecting lymphatic vessels are critical for the transport of lymph and its cellular contents to lymph nodes 
for both immune surveillance and the maintenance of tissue-fluid balance. Collecting lymphatic vessels drive lymph 
flow by autonomous contraction of smooth muscle cells that cover these vessels. Here we describe methods using 
intravital microscopy to image and quantify collecting lymphatic vessel contraction in mice. Our methods allow for the 
measurement of the strength of lymphatic contraction of an individual lymphangion in a mouse, which has not yet been 
demonstrated using other published methods. The ability to study murine collecting lymphatic vessel contraction—using 
the methods described here or other recently published techniques—allows the field to dissect the molecular mecha-
nisms controlling lymphatic pumping under normal and pathological conditions using the wide variety of molecular tools 
and genetic models available in the mouse. We have used our methods to study lymphatic contraction in physiological 
and inflammatory conditions. The methods described here will facilitate the further study of lymphatic function in other 
pathological conditions that feature lymphatic complications. 
Keywords: lymphatic vessels, lymphatic contraction, intravital imaging, physiology
INTRODUCTION
The initial lymphatic vessels have discontinuous endothelial cell 
junctions and lack pericyte coverage. These features provide a highly 
permeable environment that facilitates the collection of extracellular 
fluid, macromolecules and cells. In contrast to initial lymphatic ves-
sels, the collecting lymphatic endothelial cells are tightly connected 
by junctional molecules and are covered by smooth muscle cells [2]. 
Intraluminal valves are anatomically distributed along the collecting 
lymphatic vessels in order to prevent back flow [3]. The regions be-
tween the valves are called lymphangions, which are the functional 
pumping units of the lymphatic system [4]. Lymphatic smooth muscle 
cells (SMCs) are highly organized in covering the lymphangion, but 
are discontinuous over the valves [1]. The contractions of these SMCs 
drive lymph flow through collecting lymphatic vessels to lymph nodes 
and, in more proximal lymphatic vessels, propel lymph back to the 
central circulation. Disruption of lymphatic drainage results in tissue 
fluid accumulation. Continuous accumulation of fluid may eventually 
lead to lymphedema—a disfiguring swelling for which there are limited 
therapies and no cure. Lymphedema carries a huge psychosocial burden 
and forms conditions for infection of the affected tissue. To understand 
the molecular regulation of lymphatic function in disease states, it is 
necessary to have methods to study lymphatic contraction in an animal 
species with robust molecular and genetic tools available. Here we 
present an experimental protocol for use in mice to study autonomous 
lymphatic contraction in vivo.  
Overview of the technique
The experimental setup for the surgical procedure to study murine 
autonomous lymphatic contraction is found in Figure 1 and Movie 
S1, and uses fluorescence microlymphangiography that was originally 
developed to measure initial lymphatic vessels in humans [5]. We found 
that the afferent collecting lymphatic vessels to the popliteal lymph node 
(PLN), which extend from the footpad to the PLN, exhibit consistent 
lymphatic contraction. Briefly, after administration of anesthesia, we 
inject 2-3 μl of fluorescent dye subcutaneously into the footpad. Next, we 
carefully excise a small piece of skin and expose the afferent lymphatic 
vessels to the PLN (PLVs). The mouse is then transferred to a petri 
dish and placed onto the stage of an inverted fluorescent microscope to 
visualize lymphatic contraction. Although we use visible wavelength 
epifluorescence microscopy to image lymphatic contraction, any high-res-
olution imaging technique with at least 10 frames per second that can 
visualize lymphatic vessels can be adapted to these methods, including 
brightfield videomicroscopy, video-rate multiphoton microscopy [6] 
and near-infrared epifluorescence imaging [7].
Comparison with other techniques 
Lymphatic contraction has been studied in larger animals, such as 
rat or rabbit. Both in vivo and ex vivo techniques have been developed 
and show a critical role for smooth muscle cells in lymphatic contrac-
tion [8]. However, limited molecular and genetic tools, as well as few 
disease models in these species, have prevented further study and the 
advancement of our understanding of lymphatic contraction. Thus, 
developing methods to study lymphatic contraction in the mouse is 
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timely and significant. 
In addition to the methods described in this protocol, several groups 
have recently adapted techniques to image different aspects of lymphatic 
contraction in mice that were originally developed for larger animals. 
The two main optical methods adapted to mice with sufficient temporal 
resolution to measure lymphatic vessel contraction—which excludes 
many radiographic and magnetic resonance based techniques that can 
measure other aspects of lymphatic function [9,10]—are ex vivo single 
vessel isolation preparations [11] and non-invasive near-infrared fluo-
rescence imaging [12-15], each with their limitations (Table 1). Isolated 
lymphatic vessel preparations permit high resolution and sharp contrast 
of the wall of the lymphatic vessel, which can be analyzed to quantify 
the strength of individual lymphatic contractions (Ejection Fraction) 
and their frequency [16,17]. Data from isolated vessel experiments in 
larger animals have yielded great insight into pressure and flow rela-
tionships as well as the response of these vessels to pharmacological 
interventions [16-30]. However, ex vivo preparations lack the physiolog-
ical and molecular cues found in vivo, limiting their ability to develop 
comprehensive models of lymphatic function [31]. The methods we 
present here for the mouse, similar to other surgical methods to image 
lymphatic contraction in larger animals [32-34], allow for vessel wall 
movement and the strength of individual lymphatic contractions to be 
measured while maintaining the dynamic physiological and molecular 
environment found in vivo.
Using near-infrared fluorescence imaging, which allows deeper 
imaging in tissue than visible wavelengths, the phasic activity of con-
tracting lymphatic vessels has been studied non-invasively in mice 
[7,12-15,35]. Near-infrared fluorescence techniques have also been 
used in humans to study lymphatic drainage and phasic activity in 
cancer and lymphedema patients [36-38]. This seminal work allows 
the longitudinal study of lymphatic function, facilitating the evaluation 
of therapeutic interventions in disease states. Applied to the mouse, 
longitudinal, large field and non-invasive monitoring is advantageous, 
highlighted by the ability to show the re-routing of lymphatic drainage 
in metastatic tumors during disease progression [7]. The non-invasive 
near-infrared technique can measure the movement of lymph fluid over a 
distance much larger than a single lymphangion, which is a limitation of 
the isolated vessel technique and the method presented in this protocol. 
Interestingly, the frequency of the long-range transport is much slower 
than the contractions of a lymphangion measured using isolated vessel 
techniques or the method presented in this protocol. This discrepancy 
may be potentially explained by the complicated relationship between 
the contraction of individual lymphangions and the dynamics of intra-
luminal lymphatic valves that regulate the forward propagation of flow 
[39,40]. Due to the optical properties of the tissue and skin, measuring 
the dynamics of the lymphatic vessel wall and ejection fraction is not 
currently reliable with the non-invasive technique, independent of the 
optical probe chosen. Light scattering from the overlying skin and 
tissue distorts the imaged vessel diameter with errors of over 100% 
at 2 mm of depth and over 1000% at 5 mm of depth for near-infrared 
optical probes [41]. The use of near-infrared fluorescence can be used 
in the surgical method described here in order to measure the strength 
of individual lymphatic contractions, combining the optical advantages 
of imaging in the near-infrared (e.g. reduced auto-fluorescence) with 
the ability to resolve vessel wall dynamics. Finally, the ability to study 
the interaction of cells (e.g. smooth muscle cells, dendritic cells, tumor 
cells) and the contracting lymphatic vessel has not been demonstrated 
with the non-invasive near-infrared technique, which is an advantage 
of the method described in this protocol.
Advantages and limitations
The method presented in this protocol allows for imaging with 
high spatial and temporal resolution, which permits measurement of 
lymphatic vessel wall motion over time and allows the study of the 
interaction between the lymphatic vessel, smooth muscle and immune 
cells in vivo. This method also preserves the in vivo context for lymphatic 
contractions, allowing the effects of nervous system control, systemic 
molecular regulation and disease processes to be studied. In addition, the 
vast array of genetic and molecular tools available in mice can be used 
to dissect molecular mechanisms of lymphatic contraction. However, 
since this is an acute method, each mouse can only have one imaging 
session. In addition, surgery may interrupt the connective tissue and 
may have subtle effects on the lymphatic contraction. In some disease 
conditions, the lymphatic microenvironment is dramatically changed, 
including disease processes that cause fibrosis or fat formation. Under 
these conditions, removing the connective tissue in order to image lym-
phatic vessels may alter the true function of these vessels. Thus, using 
all available techniques, including non-invasive near-infrared imaging 
and isolated vessel preparations, will allow for a robust characterization 
of lymphatic function (Table 1).
Table 1. Comparison of optical techniques with sufficient temporal resolution to measure dynamic lymphatic vessel function.
Isolated lymphatic vessel Surgical preparation Non-invasive imaging
In vivo No Yes Yes
Ability to quantify vessel diameter changes Yes Yes No
Permits longitudinal imaging No No Yes
Able to measure cell interactions Yes Yes No
Ability to accurately control pressure and flow Yes No No
Entire microstructure around vessel remains intact No No Yes
Ability to control molecular concentration around vessels Yes No No
Collecting lymphatic vessels in different tissues have different phe-
notypic and morphological characteristics [42]. Thus, the mouse PLV 
may not represent mesenteric or other collecting lymphatic vessels. 
Furthermore, the molecular mechanisms that govern murine lymphat-
ic contractions may not be the same in humans. Once a molecular 
understanding is developed and characterized in the mouse PLV, that 
framework needs to be validated in humans as well as in other ana-
tomical locations. The method presented in this protocol provides a 
research tool to help drive the discovery that allows us to explore and 
eventually better understand human lymphatic function, which will 
require further experimentation.
Although there are many optical imaging options to use with the 
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surgical method described in this protocol, we will use visible light 
epifluorescence microscopy in our example due to the simplicity and 
common availability of the microscopy hardware in biomedical research 
laboratories, as well as the good reliability of the automated image 
processing algorithm to analyze data from this simple optical set-up.
Application of the lymphatic contraction model
The molecular and physiological control mechanisms of autonomous 
lymphatic contraction are just beginning to be uncovered. The methods 
described here can help further define these control mechanisms and 
can be used to interrogate theoretical models of lymphatic contraction. 
For instance, we are developing a theoretical model in which cyclic 
production of nitric oxide can trigger the smooth muscle cell driven, 
calcium-dependent lymphatic contractions. We can use the methods 
described here to test predictions of our model as part of the model 
validation. As we develop a deeper understanding of the molecular and 
cellular players involved in autonomous lymphatic contraction, we can 
use conditional and inducible genetic murine models to intervene in the 
purported pathways. Furthermore, the availability of transgenic reporter 
mice that highlight the lymphatic vessels can be utilized to eliminate 
the need for the lymphangiography injection [43]. We can also use 
multiple colored labels to highlight different cell types in order to study 
their interactions in a contracting lymphatic vessel. In this way, the 
methods described here provide another tool for researchers to develop 
a robust understanding of autonomous lymphatic vessel contraction.
In addition to studying the physiological control of lymphatic ves-
sel contraction, there is a great need to understand how perturbations 
in lymphatic contractions may affect lymphatic function in disease 
states. We have used our model of murine autonomous lymphatic 
contraction to study the molecular regulation of lymphatic contrac-
tion in inflammatory conditions [1]. As we and others have shown, 
lymphatic function changes in the presence of tumors [7,44-47]. The 
methods proposed here can be used to further explore how tumors 
alter lymphatic contraction at the molecular level and if there is any 
interaction of metastatic tumor cells with collecting lymphatic vessels 
as they travel to the lymph node. These methods can also be used to 
dissect the molecular control of lymphatic contractions in a variety of 
other disease settings in which lymphatic function is altered, including 
lymphedema, bacterial infection and filariasis.
MATERIALS
Animals
Mice aged 5-6 weeks (either sex can be used): All experiments 
using mice must be performed in accordance with all institutional and 
governmental ethics and animal handling requirements.
Reagents (Surgery and dissection reagents)
 9 Bacteriostatic 0.9% Sodium Chloride, Injection, USP (Hospira, 
Inc. cat # 01966-05)
 9 Ketamine hydrochloride (100 mg/ml) (Hospira, Inc. cat # 02051-
05) 
 9 Xylazine (100 mg/ml) (Lloyd Laboratories, cat # 139-236)
 9 0.9% Sodium Chloride Irrigation Saline, USP,(Baxter, cat # 
2F7124)
 9 Sterile Water for Irrigation, USP, (Baxter, cat # 2F7114)
 9 1 ml TB Syringe (Becton, Dickinson and Company, cat# 309659)
 9 Polyethylene Tubing 0.28 mm (0.011") O.D. 0.61 mm (0.024") 
(Intramedic, Becton, Dickinson and Company, cat # 427401)
 9 30G × ½ needle  (0.29 mm × 13 mm) (Becton, Dickinson and 
Company, cat # 304000)
 9 Fluorescent dye (2% fluorescein isothiocyanate (FITC)- dextran 
or rhodamine-dextran), average molecular weight 2,000,000 Da 
(Sigma Aldrich cat # FD2000S) 
 9 100% ethanol (Sigma-Aldrich, cat # E7023)
 9 3" by 3" Cover sponges (Curity/Covidien Inc. cat #1700)
 9 Sterile Cell Culture Dish (Corning, cat # 430167) or Petri dish 
(Becton Dickinson cat # 351005)
Equipment
 9 Olympus IX70 Inverted Epi-Fluorescence Microscope
 9 Prior Automatic Stage H107P1X
 9 Prior OptiScan Motorized Stage System
 9 Prior Lumen 200 Fluorescent Illumination System
 9 Hamamatsu ORCA-ER Digital Camera
 9 Hamamatsu ORCA-ER Camera Controller 
 9 WIBA and MNG Filter cubes for FITC and Rhodamine visual-
ization, respectively
 9 Improvision ORBIT Filter/Shutter Control
 9 Olympus 20X 0.40 LCPlanFL Objective
 9 Stage Heater (custom-built by Massachusetts General Hospital 
Machine Shop)
 9 Tenma Laboratory DC Power Supply
 9 Omega CN132 Autotune Temperature/Process Dual Setpoint 
Controller
 9 Openlab Imaging Software (Perkin Elmer) 
 9 Surgical tools (Sterilize surgical instruments before the proce-
dure): IRIS scissors (World Precision Instruments (WPI) cat 
# 500216-G); VANNAS scissors (WPI, cat # 14122-G); IRIS 
scissors (WPI, cat # 14218-G), forceps Dumont #3 (WPI, cat # 
500337); forceps Dumont #5 (WPI, cat # 500233); IRIS Forcep 
straight (WPI,  cat # 15914); IRIS Forcep curved (WPI, cat # 
15915)
 9 Dissecting Microscope: Nikon SMZ-2T stereomicroscope with 
Micro Video Instruments Illuminator.
 9 Stereomicroscope: Nikon SMZ1500 stereomicroscope with Nikon 
NI-150 fiber optic illuminator and Nikon Intensilight C-HGFI 
mercury-fiber illuminator.
 9 Injection Apparatus: Connect one end of polyethylene tubing to 
30G × ½ needle. Attach a 1ml TB syringe to the needle. Dislodge 
needle shaft from another 30G × ½ needle. Insert the blunt end 
of the 30G × ½ needle shaft into the other end of the tubing. The 
inside diameter of this tubing is 0.28mm. Thus, 1.6 cm of fluid 
in the tubing is 1 μl. See Figure S1 and Movie S1.
Recipes
 9 Ketamine/Xylazine Anesthetic: For 1 ml of anesthetic solution, 
combine i) 3 ml of 100 mg/ml ketamine hydrochloride, ii) 0.3 ml 
of 100 mg/ml xylazine and iii) 27 ml of bacteriostatic 0.9% (wt/
vol) NaCl. The solution should be freshly prepared before use.
 9 Fluorescent Tracer: For 1 ml of FITC-dextran, add 0.02 g 
FITC-dextran to 1 ml sterile water.
 9 70% Ethanol Solution: To make 10 ml of 70% ethanol, mix 7 
ml 100% ethanol with 3 ml sterile water.
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PROCEDURE
Surgery to expose afferent lymphatic vessels to the popliteal lymph node (Timing: 20 min) 
A visual presentation of the procedure can be found in Movie S1.
1. Inject 200 µl ketamine/xylazine intraperitoneally (i.p.) to anesthetize the mouse. Wait until the mouse is completely 
asleep (about 5 min). Surgery can be performed when the animal no longer reacts to a toe pinch. 
CAUTION: Appropriate permission must be obtained prior to performing animal experiments and surgeries. 
Multiple strains of mice have been tried using our methods, yielding similar results. The age of the animal is a 
bigger source of variation so care should be taken to control for mouse age.
2. Inject 2-3 µl 2% FITC-dextran (molecular weight 2,000,000 Da) in PBS subcutaneously into the footpad using 
the injection apparatus. After filling the entire apparatus with saline, a small air bubble can be introduced in the 
tip of the injection needle. Then the fluorescent dye can be drawn into the tubing, with the air bubble separating 
the fluorescent dye and the saline. The distance the air bubble travels and the cross sectional area of the tubing 
can be used to measure the volume of dye injected. Massage footpad gently to stimulate fluorescent dye uptake.
TIP: The small amount of liquid is difficult to control using syringe alone, therefore we recommend the use of 
the injection apparatus. 
3. Surgical removal of skin over the lymphatic area: Shave fur from right hind leg. Place the mouse in the prone po-
sition, with the lymphatic area facing up (Fig. 1A). Place a piece of tape across the footpad. Next, place a piece of 
tape across the lower abdomen. Wet the hindlimb with 70% ethanol to sterilize the surgical area. Make an incision 
parallel to the caudal femoral artery and caudal branch of the lateral saphenous vein starting at the ankle of the 
mouse and directed proximally (Fig. 1B-C). Once the incision approaches the popliteal fat pad, make a transverse 
cut opposite the PLN. The artery, vein and PLVs should be exposed. Remove the flap of skin by making a parallel 
cut down the leg in the opposite direction of the first incision (Fig. 1D). Under the dissecting microscope, ensure 
that the vessels are clearly exposed.
TIP: Apply a modest amount of 70% ethanol to skin with fingertips. Spraying ethanol will cause tape to lose 
adhesiveness, leading to inefficient surgery.
CAUTION: The lymphatic vessels run parallel with the blood vessels that perfuse the lower leg. Take care not to 
damage any blood vessel, especially the caudal femoral artery.
                  
Figure 1: Preparation of mouse to study 
autonomous collecting lymphatic con-
traction. A. The hindlimb of the mouse 
is shaved and placed prone on a heated 
surface for performing microsurgery. B. After 
immobilizing the mouse with tape and ster-
ilizing the area with 70% ethanol, a small 
incision is made starting at the back of the 
ankle and running toward the back of the 
knee along the medial aspect. C. The view 
through stereomicroscope of incision in (B). 
D. After the PLV is identified, a flap of skin 
is removed to allow for intravital microsco-
py. The fat surrounding the PLV is bluntly 
dissected without damaging any vessels. 
E. The view through the stereomicroscope 
(left) and a fluorescent view of the PLVs 
running with the caudal branch of the lateral 
saphenous vein (right). Red arrow identifies 
PLV. F. The PLV is placed flat against the 
bottom of a petri dish with the mouse in a 
“seated” position. Saline is applied to keep 
the exposed tissue wet. G. The mouse and 
petri dish are placed on a heated stage to 
maintain the body temperature of the mouse. 
H. The mouse, petri dish and heated stage 
are placed on the inverted fluorescence 
microscope.
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4. Apply physiological saline solution to hydrate the exposed area.
5. Under the dissecting microscope, cautiously remove fat and connective tissue from around the lymphatic vessels 
with Dumont #5 forceps and blunt dissection. This improves the optical quality and is needed for high-resolution 
imaging (Fig. 1E). OPTIONAL: The quality of the surgical preparation and fluorescence filling of the PLV can 
be checked using the stereomicroscope prior to Step 6.
CAUTION: Do not damage lymphatic vessels. Damage to lymphatic vessels results in loss of contraction and 
unreliable results.
Preparing the mouse for imaging
6. Place mouse in a 10 cm petri dish. Gently position the exposed lymphatic vessels flatly on the bottom of dish. 
TIP: The leg needs to be in contact against the bottom of the dish; otherwise images of the PLV will not be in 
focus across the length of the vessel.
7. Place tape across the toes to secure the foot and another piece of tape on the upper thigh to fix the mouse leg 
in the petri dish. Use a piece of wide tape to support the neck in order to allow the mouse to stay in an upright, 
seated position (Fig. 1F).
NOTE: Do not tape the footpad or the leg too tightly. This may cause extra pressure and could interrupt the 
lymphatic contraction. Tape should be loosely applied and the vessel inspected to make sure it is not compressed.
8. Apply 500 µL of NaCl solution to the exposed leg in order to keep the tissue hydrated during the procedure.
NOTE: The heated stage will cause evaporation of the saline solution. Monitor the level of this solution to prevent 
dehydration of exposed leg tissue during imaging.
9. Place the petri dish (containing the mouse) in the heating unit to maintain body temperature (Fig. 1G).
Intravital imaging (Timing: 75 min)
10. Allow the mouse to rest on stage for 10-15 min (Fig. 1H) to stabilize the contractions. Set up microscope to excite 
and detect FITC fluorescence. The resting period is needed for the vessel to adjust to its dependent position from 
the prone position during the surgery, to better regulate the temperature and to avoid measuring transients due to 
the lymphangiography injection.
11. Adjust the focus in order to visualize the lymphatic vessels.
12. Using the imaging software, modify camera contrast levels in order to optimize conditions for later analysis.
NOTE: High contrast will lead to indiscriminate fluctuations at lymphatic vessel borders, while low contrast may 
cause background signals to be included in areas selected for quantitation. The full dynamic range of the detection 
system should be utilized and pixel saturation should be avoided.
13. Observe the lymphatic contractions under the microscope.
14. Acquire time-lapse images for about 30 s. For instance acquire 360 frames at 80 ms/frame (28.8 s). Move stage in 
order to focus on an adjacent segment of the lymphatic vessel, and take another time-lapse sequence. These will 
be the two segments recorded for the mouse.
NOTE: These camera settings can be adapted based on the specific camera available.
15. After 10 min, re-position to focus on each of the prior segments and continue to acquire time-lapse images. Repeat 
every 10 min for one hour to generate 7 movies per segment to quantify the lymphatic contraction properties of 
that segment. 
TIP: Animals that have wide variations from the beginning to the end of the imaging session likely have some 
problem associated with the surgical procedure and should be excluded. We recommend imaging over the course 
of an hour in order to verify that the pumping is at a steady state and is thus representative of the homeostatic 
baseline. Of note, in an individual animal, particularly in a pathological state, it is hard to determine whether the 
lack of lymphatic pumping is due to the disease or the surgical preparation in that animal. Each investigator should 
establish their failure rate in control animals. One would not expect an experimental failure in every mouse with 
a pathological process. Using the control failure rate in statistical power calculations allows proper experimental 
design and group size in order to make appropriate comparisons of the disease state as a group compared to the 
control state as a group.
16. Save the images for processing.
Timing
The entire protocol should take about 95 min to generate the con-
traction data. This involves 20 min for the preparation of the PLV 
model and 75 min for intravital imaging. Image processing occurs 
off-line and timing will depend on computational speed and number 
of experiments analyzed.
Image Processing 
Our method of lymphatic pumping signal analysis is called the 
Peak-and-Valley analysis. First we process the time-lapse images of 
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contracting lymphatic vessels to identify the upper and lower boundaries 
of the vessel (Movie S2) using custom Matlab code (Supplemental In-
formation). We then create plots of the average vessel diameter against 
time and identify the peaks (maximum diameters when dilated) and 
valleys (minimum diameters when constricted) in the curve with the 
algorithm summarized below:
A point is considered a peak/valley if it is the local maxima/minima, 
and is followed by a diameter measurement of lower/higher value. A 
user-defined threshold, which is also reviewed by the user after initial 
processing, is used to identify the size of the required change in order 
to filter out the noise in the system. Furthermore, peaks and valleys can 
only appear alternatively in the results. This method robustly identifies 
peaks and valleys on relatively regular lymphatic pulsing signals as 
well as noisier signals (Fig. 2). 
We can then use these data to calculate the contraction frequency, 
contraction amplitude, ejection fraction and lymph output as described 
(Fig. 3).
Figure 2. Peak and Valley analysis is able to calculate a representative 
frequency and amplitude from a noisy sample of lymphatic pulsing 
as recorded in our study. Blue curve shows the recorded average vessel 
diameter. Red and green asterisks indicate identified peaks and valleys, 
respectively.
       
Figure 3. Quantification 
of lymphatic contrac-
tion. Vessel diameters are 
measured over time and 
from these measurements 
we calculate contraction 
amplitude, contraction 
frequency, ejection frac-
tion and lymph output. 
The ejection fraction is a 
measure of the fraction 
of fluid that is driven out 
of the vessel with each 
contraction. This gives a 
measure of the strength 
of lymphatic contraction. 
The lymph output is a 
measure of the amount of 
lymph pumped per time 
normalized to a unit length 
of vessel.
Frequency f is calculated as the following:
1 1
1 1
0.5M N
peak peak valley valley
M Nf
t t t t
 − −
= + × 
− −                       (Eqn. 1)
where M and N are respectively the total numbers of peaks and 
valleys in the signal; 1
peakt  and 
M
peakt  are respectively the time when the 
first and Mth peaks appear; 1
valleyt  and  
N
valleyt  are respectively the time 
when the first and Nth valleys appear. 
We calculate the amplitude as the displacement from the average 
diameter of the collecting lymphatic vessel. Because the baseline 
lymphatic diameter is different under each experimental condition, it is 
more appropriate to compare the relative, instead of absolute, amplitude 
of the contraction signals. The normalized amplitude from the average 
diameter A is calculated by the following for each period in the signal:
,1 ,2
,1 ,2
0.5peak valley peak valley
peak valley peak valley
D D D D
A
D D D D
 − −
= + ×  + +                   (Eqn. 2)
where 
peakD  is the diameter of the peak, ,1valleyD  is the diameter of 
the preceding valley and 
,2valleyD  is the value of the subsequent valley. 
The value A is then averaged over all the periods in the signal. 
We can further estimate the total volumetric fraction of lymph that 
is pumped by the lymphatic vessel and a theoretical lymph output by 
integrating the change in vessel volume over all the time steps in the 
time-lapse movie, assuming that the images are taken at the center of 
the vessel which is perfectly cylindrical:
( )1 10; , , 1, 2, ,out i i out out i iV V V V V V V i K+ += < = + − = …      (Eqn. 3)
 
Ejection Fraction out
vessel
V
V M
=
                    (Eqn. 4)
( )
Lymph Output
1
out
vessel
V
L t K∆
=
−                 
(Eqn. 5)
where  outV is the total volume of lymph pumped out of the lymphatic 
vessel during the 30 second movie; K is the number of time steps in 
the time-lapse movie;  , 1, 2, ,iV i K= …  is the volume of the lymphatic 
vessel at the ith time step; t∆  is the length of each time step; vesselV  
is the time-averaged volume of the lymphatic vessel; M is the total 
number of peaks in the signal and vesselL  is the length of the lymphatic 
segment. The lymph output is a theoretical value based solely on the 
vessel wall movement and geometry of the vessel. Based on valve 
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patency, the status of adjacent lymphangions and other driving forces, 
actual lymph output may be different. The main utility is to incorporate 
the frequency component with the strength of lymphatic contraction 
into a single metric.
ANTICIPATED RESULTS
Typical contractions of the PLV under normal conditions are shown 
in Movie S2. After processing this movie, we obtained the lymphatic 
contraction profile (Fig. 2) and relevant parameters in Table 3. The 
diameter changes between 33 μm to 45 μm and this vessel contracts 36 
times per minute. For each contraction, 58% of the volume was ejected 
(Ejection Fraction) and 469 μm3 volume is ejected per second normal-
ized to 1 μm of lymphatic vessel length (Lymph Output). Intraluminal 
collecting lymphatic valves are critical for maintaining unidirectional 
lymph flow [45]. Using our methods, we are able to visualize the valve 
motion and study it during disease processes. Movie S3 shows the 
typical valve motion during physiological conditions.
The methods to image autonomous lymphatic contraction presented 
here also permit the study of lymphatic contraction in disease states, 
with the ability to dissect both cellular and molecular mechanisms. For 
example, we have transplanted β-actin GFP transgenic mouse bone 
marrow to a lethally irradiated wild type mouse. After 8 weeks of re-
covery, we measured lymphatic vessel contraction and their interaction 
with bone marrow derived cells during physiological and inflammatory 
conditions. To induce inflammation, 100 μL of 4% oxazolone (Sigma) 
in acetone was applied topically to all of the skin area surrounding the 
lower leg, but not touching the skin over the paw.
Under physiologic conditions, there are few bone marrow derived 
cells adjacent to the lymphatic vessel. However, some bone marrow 
derived cells appear to directly interact with the lymphatic vessel. 
Under inflammatory conditions, the strength of lymphatic contraction 
is inhibited (Movie S4) and a large amount of bone marrow derived 
cells accumulate near the lymphatic vessel (Fig. 4). Using the surgical 
hindlimb method to image lymphatic contraction, one can also resolve 
cells inside the lymphatic vessels and measure their movement within 
the vessel. 
Table 2. Troubleshooting Table.
Step Problem Possible Reason Solution
2 Lymphangiography injection
Difficulty in controlling 
the injection volume 
and force.
Injecting small amounts of liquid in a controlled way is challenging. We recommend using the 
injection apparatus described in the in the Reagent Setup (Figure S1). After filling the entire appa-
ratus with saline, a small air bubble can be introduced in the tip of the injection needle. Then the 
fluorescent dye can be drawn into the tubing, with the air bubble separating the fluorescent dye 
and the saline. The distance the air bubble travels and the cross sectional area of the tubing can 
be used to measure the volume of dye injected.
Difficulty in filling the 
PLV
Subcutaneously inject into the center of the footpad. Injection at the periphery will cause inefficient 
uptake of FITC-dextran.
3
Cannot locate lym-
phatic vessels
Unfamiliarity of loca-
tion of PLV
For beginners, inject Evans Blue dye at the footpad instead of fluorescent dye using the injection 
apparatus. Lymphatic vessels will be highlighted in blue.
Trouble immobilizing 
the leg for the surgery
Dermal tape is not 
sticking
Apply a modest amount of ethanol to skin with fingertips. Spraying ethanol will cause tape to lose 
adhesiveness, leading to inefficient surgery.
11 Lymphatic vessels are not clearly visible
Removal of fat is in-
adequate
Fat tissue may block the fluorescent signal during imaging and distort the optical image. Remove 
as much fat as possible with Dumont #5 forceps and blunt dissection. (See Step 5)
Tissue injury during 
surgery
Make sure that no blood or lymphatic vessels are injured, resulting in blood hemorrhage or dam-
age along the lymphatic vessels. 
Incorrect positioning 
of leg in petri dish
Make sure the leg is placed against the bottom of the petri dish. This allows for the vessel to re-
main in focus along its length. (See Step 6).
12
Lymphatic vessel 
contrast is too faint or 
too intense.
Volume of injected 
FITC-dextran was in-
appropriate.
Use a piece of polyethylene tubing to connect 30G × ½ needle. With this simple device, the in-
jection can be gentle and the small volume can be controlled easily (See Reagent Preparation. 
Fig. S1).
Site of injection was 
inaccurate
Inject into the center of the footpad. Injection at the periphery will cause inefficient uptake of 
FITC-dextran. (See Step 2).
13 Lymphatic vessels not contracting
Lymphatic vessel 
damage during sur-
gery.
Overambitious removal of fat or rough handling of the surgical preparation can cause damage to 
the lymphatic vessels, leading to leakage of FITC-dextran or failure of lymphatic vessels to con-
tract. During surgery, care should be taken not to puncture the lymphatic vessels or move it from 
its normal position.
Sub-optimal environ-
ment
Wait at least 15 min for mouse to adjust to imaging conditions. Make sure the animal temperature 
is maintained at 37°C.
Leg taped too tightly 
impairing vasculature
Taping the leg too tightly to the petri dish bottom can impair flow. Loosen the tape, while still keep-
ing the PLV flat along the petri dish bottom (See Step 7).
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Figure 4. Lethally irradiated C57/Bl6 mice were rescued with bone 
marrow from a β-actin GFP transgenic mouse. A. Under physiologic 
conditions there is a modest number of bone marrow derived cells (green) 
around the PLV (red). B. Under inflammatory conditions (four days after 
oxazolone skin painting), there is a substantial infiltrate of bone marrow 
derived cells, which are associated with an impairment in lymphatic func-
tion (Movie S4). We have shown that iNOS expression by bone marrow 
derived cells contribute to the functional impairment in collecting lymphatic 
vessels [1].
We found that these bone marrow cells inhibit the lymphatic contrac-
tion through expression of iNOS and production of nitric oxide. Using 
a genetically modified mouse deficient in iNOS, lymphatic contractions 
could occur even during inflammation [1]. These results indicate that 
lymphatic contraction can be impaired during disease processes and 
the methods presented here allowed the dissection of the molecular and 
cellular mechanisms. Understanding these and additional molecular 
mechanisms may lead to new strategies for the treatment of lymphedema 
and diseases associated with lymphatic impairment.
Table 3. Parameters calculated from Movie S2.
Min diameter (μm) Max diameter (μm) Frequency (cpm) Amplitude (%) Ejection Fraction (%) Lymph Output (μm3/s/μm)
33 46 36.3 16 58 469
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Supplementary information
Movie S1. Movie of the experimental procedures described in this 
Protocol.
Movie S2. Autonomous contraction of the PLV. The edge of the 
contracting vessel is highlighted in red by the edge-finding algorithm 
of the image processing and analysis software. Scale bar=25 μm.
Movie S3. Intraluminal valve motion is visible during lymphatic 
contraction. Scale bar=25 μm.
Movie S4. Lymphatic contraction is severely impaired along with 
PLV dilation during inflammation. The edge of the vessel is highlight-
ed in red by the edge-finding algorithm of the image processing and 
analysis software. Scale bar=25 μm.
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